Completed NA INTERVENTIONAL 2-arm NCT00708032

Clinical Performance of a New Daily Disposable Contact Lens Worn in a Neophyte Population.

Sponsor: Johnson & Johnson Vision Care, Inc.

Interventions narafilcon A soft contact lenses spectacles

Updated 8 times since 2017 Last updated: Dec 3, 2019 Started: Jun 1, 2008 Primary completion: Dec 1, 2009 Completion: Dec 1, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00708032, this NA trial focuses on Myopia and Refractive Error and remains completed. Sponsored by Johnson & Johnson Vision Care, Inc., it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2020 — Jan 2021 [monthly]

Completed NA
Dec 2019 — Jan 2020 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Dec 2019 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johnson & Johnson Vision Care, Inc.
University of Manchester

Data source: Johnson & Johnson Vision Care, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Manchester, United Kingdom